Chiara Bertagnin

430 total citations
19 papers, 304 citations indexed

About

Chiara Bertagnin is a scholar working on Epidemiology, Molecular Biology and Oncology. According to data from OpenAlex, Chiara Bertagnin has authored 19 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 10 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Chiara Bertagnin's work include Influenza Virus Research Studies (13 papers), Cancer-related Molecular Pathways (5 papers) and RNA and protein synthesis mechanisms (4 papers). Chiara Bertagnin is often cited by papers focused on Influenza Virus Research Studies (13 papers), Cancer-related Molecular Pathways (5 papers) and RNA and protein synthesis mechanisms (4 papers). Chiara Bertagnin collaborates with scholars based in Italy, China and Sweden. Chiara Bertagnin's co-authors include Arianna Loregian, Beatrice Mercorelli, Marta Celegato, Giorgio Palù, Xinyong Liu, Serena Massari, Giulio Nannetti, Ruifang Jia, Xiuli Ma and Oriana Tabarrini and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Chiara Bertagnin

19 papers receiving 302 citations

Peers

Countries citing papers authored by Chiara Bertagnin

Since Specialization

Citations

This map shows the geographic impact of Chiara Bertagnin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Bertagnin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Bertagnin more than expected).

Fields of papers citing papers by Chiara Bertagnin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Bertagnin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Bertagnin. The network helps show where Chiara Bertagnin may publish in the future.

Co-authorship network of co-authors of Chiara Bertagnin

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Bertagnin. A scholar is included among the top collaborators of Chiara Bertagnin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Bertagnin. Chiara Bertagnin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Exploring a New Generation of Pyrimidine and Pyridine Derivatives as Anti-Influenza Agents Targeting the Polymerase PA–PB1 Subunits Interaction 2024 ·Pharmaceutics ·(unknown), (unknown), Chiara Bertagnin, (unknown), Valeria Francesconi, Mattia Mori, Anna Carbone, Francesca Musumeci, Arianna Loregian, Silvia Schenone	1
2	Elaborate Structural Modifications Yielding Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Potent Neuraminidase Inhibitors with Significantly Improved Broad-Spectrum Antiresistance Profiles 2024 ·Journal of Medicinal Chemistry ·(unknown), Ruifang Jia, (unknown), Ping Li, (unknown), (unknown), Chiara Bertagnin, Q. Xu, Zhou Tan, Xiuli Ma, Arianna Loregian, Bing Huang, Xinyong Liu, Peng Zhan	2
3	Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization 2024 ·European Journal of Medicinal Chemistry ·(unknown), Tommaso Felicetti, (unknown), Chiara Bertagnin, Alice Coletti, (unknown), Marta De Angelis, (unknown), Antonio Macchiarulo, Stefano Sabatini, Beatrice Mercorelli, Lucia Nencioni, Ilaria Vicenti, Elena Dreassi, Violetta Cecchetti, Oriana Tabarrini, Arianna Loregian, Serena Massari	5
4	Discovery of N-substituted oseltamivir derivatives as novel neuraminidase inhibitors with improved drug resistance profiles and favorable drug-like properties 2023 ·European Journal of Medicinal Chemistry ·Ruifang Jia, Jiwei Zhang, Fangyuan Shi, (unknown), (unknown), Chiara Bertagnin, Jian Zhang, Chuanfeng Liu, (unknown), (unknown), Xiuli Ma, Arianna Loregian, Bing Huang, Peng Zhan, Xinyong Liu	6
5	A novel N -heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation 2023 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Jiwei Zhang, Chuanfeng Liu, Ruifang Jia, Xujie Zhang, Jian Zhang, Chiara Bertagnin, (unknown), (unknown), (unknown), (unknown), (unknown), Xiuli Ma, Arianna Loregian, Bing Huang, Peng Zhan, Xinyong Liu	2
6	Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines 2023 ·Organic & Biomolecular Chemistry ·(unknown), (unknown), Tommaso Felicetti, (unknown), (unknown), M. TIECCO, Chiara Bertagnin, Maria Letizia Barreca, Raimondo Germani, Violetta Cecchetti, Ilaria Vicenti, Oriana Tabarrini, Maurizio Zazzi, Arianna Loregian, Serena Massari	5
7	A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells 2023 ·Cancer Letters ·Chiara Bertagnin, (unknown), Matteo Pavan, Marta Celegato, Mattia Sturlese, Beatrice Mercorelli, Stefano Moro, Arianna Loregian	16
8	Discovery of Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant 2022 ·Molecules ·Ruifang Jia, Jiwei Zhang, Jian Zhang, Chiara Bertagnin, (unknown), (unknown), Zhen Gao, (unknown), Zhuo Li, Chuanfeng Liu, Han Ju, Xiuli Ma, Arianna Loregian, Bing Huang, Peng Zhan, Xinyong Liu	12
9	Iterative Optimization and Structure–Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors via Targeting 150-Cavity 2022 ·Journal of Medicinal Chemistry ·Han Ju, (unknown), Fabao Zhao, Ying Zhang, Ruifang Jia, (unknown), (unknown), Jiwei Zhang, Zhen Gao, (unknown), Chiara Bertagnin, (unknown), Xiuli Ma, Dongwei Kang, Arianna Loregian, Bing Huang, Xinyong Liu, Peng Zhan	12
10	Targeted Disruption of E6/p53 Binding Exerts Broad Activity and Synergism with Paclitaxel and Topotecan against HPV-Transformed Cancer Cells 2021 ·Cancers ·Marta Celegato, (unknown), Chiara Bertagnin, Beatrice Mercorelli, Arianna Loregian	15
11	The Dimeric Form of HPV16 E6 Is Crucial to Drive YAP/TAZ Upregulation through the Targeting of hScrib 2021 ·Cancers ·(unknown), Marta Celegato, Chiara Bertagnin, Beatrice Mercorelli, Gualtiero Alvisi, Lawrence Banks, Giorgio Palù, Arianna Loregian	11
12	Identification of C5-NH₂ Modified Oseltamivir Derivatives as Novel Influenza Neuraminidase Inhibitors with Highly Improved Antiviral Activities and Favorable Druggability 2021 ·Journal of Medicinal Chemistry ·Han Ju, N. Arul Murugan, (unknown), Ping Li, (unknown), Ying Zhang, Chiara Bertagnin, (unknown), Dongwei Kang, Ruifang Jia, Xiuli Ma, Ruikun Du, Vasanthanathan Poongavanam, Arianna Loregian, Bing Huang, Xinyong Liu, Peng Zhan	15
13	1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors 2021 ·European Journal of Medicinal Chemistry ·(unknown), Tommaso Felicetti, Chiara Bertagnin, (unknown), (unknown), Maria Letizia Barreca, Violetta Cecchetti, Dirk Jochmans, Steven De Jonghe, Johan Neyts, Arianna Loregian, Oriana Tabarrini, Serena Massari	25
14	Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity 2020 ·European Journal of Medicinal Chemistry ·Ruifang Jia, Jian Zhang, Chiara Bertagnin, Srinivasulu Cherukupalli, (unknown), Xiao Ding, Zhuo Li, Jiwei Zhang, Han Ju, Xiuli Ma, Arianna Loregian, Bing Huang, Peng Zhan, Xinyong Liu	21
15	Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase 2020 ·European Journal of Medicinal Chemistry ·Serena Massari, Chiara Bertagnin, (unknown), Anna Donnadio, Giulio Nannetti, Tommaso Felicetti, (unknown), (unknown), (unknown), Giuseppe Manfroni, Marı́a Isabel Loza, Stefano Sabatini, Violetta Cecchetti, José Brea, Laura Goracci, Arianna Loregian, Oriana Tabarrini	27
16	A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth 2019 ·Cancer Letters ·Marta Celegato, (unknown), Laura Goracci, Beatrice Mercorelli, Chiara Bertagnin, Francesca Spyrakis, (unknown), A. Cousido-Siah, Gilles Travé, Lawrence Banks, Gabriele Cruciani, Giorgio Palù, Arianna Loregian	50
17	Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 2019 ·Antiviral Research ·Giulio Nannetti, Serena Massari, Beatrice Mercorelli, Chiara Bertagnin, Jenny Desantis, Giorgio Palù, Oriana Tabarrini, Arianna Loregian	26
18	Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant 2018 ·Journal of Medicinal Chemistry ·Jian Zhang, N. Arul Murugan, Ye Tian, Chiara Bertagnin, Zengjun Fang, Dongwei Kang, (unknown), (unknown), (unknown), Ruifang Jia, Ping Gao, Vasanthanathan Poongavanam, Arianna Loregian, Wenfang Xu, Xiuli Ma, Xiao Ding, Bing Huang, Peng Zhan, Xinyong Liu	40
19	A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells 2018 ·Scientific Reports ·(unknown), Marta Celegato, Chiara Bertagnin, Beatrice Mercorelli, Giulio Nannetti, Giorgio Palù, Arianna Loregian	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact